Intervention

Nicotinamide riboside

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions14

Lead sponsors shown4

Clinical trials

5 shown

Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's DementiaNCT04430517 · 2022-03-02

Mechanistic Studies of Nicotinamide Riboside in Human Heart FailureNCT04528004 · 2020-09-26

ACTIVE_NOT_RECRUITING

Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKDNCT04040959 · 2019-11-19

ACTIVE_NOT_RECRUITING

Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older AdultsNCT03821623 · 2019-05-10

ACTIVE_NOT_RECRUITING

Nicotinamide Riboside in LVAD RecipientsNCT03727646 · 2018-09-26

Common conditions

Aging1 Blood Pressure1 Heart Failure New York Heart Association Class IV1 Heart Failure NYHA Class IV1 Heart Failure, Systolic1 Heart Failure，Congestive1 Hypertension1 Kidney Disease1 Metabolic Disturbance1 Mild Alzheimer Disease1 Mild Cognitive Impairment1 Mitochondrial Alteration1 Oxidative Stress1 Vascular Diseases1

Leading sponsors

University of Washington2 Douglas Seals1 Mclean Hospital1 University of Colorado, Denver1

Trial status mix

ACTIVE_NOT_RECRUITING3

COMPLETED2

Phase mix

EARLY_PHASE13

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.